Cochennec F, Becquemin J P, Desgranges P, Allaire E, Kobeiter H, Roudot-Thoraval F
Department of Vascular Surgery, Henri Mondor Hospital, AP/HP, University Paris Val de Marne, Creteil 94000, Paris, France.
Eur J Vasc Endovasc Surg. 2007 Jul;34(1):59-65. doi: 10.1016/j.ejvs.2007.01.009. Epub 2007 Apr 2.
We reviewed our experience with limb occlusion after EVAR in order (1) to assess the clinical pattern and treatment options (2) to assess outcomes and (3) to identify predictive factors of occurrence.
Between 1995 and 2005, 460 AAA patients were electively treated with a variety of commercially available stent grafts. There were 369 bifurcated and 91 aortouniiliac grafts (829 limbs). Follow-up included physical examination, plain X-ray, Duplex ultrasonography, and spiral computed tomographic scans at 1, 6, 12 months and annually thereafter. All pertinent data were collected prospectively and analysed retrospectively. The follow-up period ranged from Day 0 to 104 months, with a median follow-up of 23.4 months.
36 limbs in 33 patients (7.2%) occluded between Day 0 and 71 months (average: 9.5 months) after EVAR. Presentation was acute ischemia in 11 cases, rest pain in 9, claudication in ten. Four occlusions remained asymptomatic and two occurred intraoperatively. Treatment was femoro-femoral cross-over graft in 19 cases, axillo-femoral bypass in three, thrombectomy and stent in three, thrombolysis and stent in nine, and conservative in two. One patient (3%) died of multiple organ failure after thrombolysis. There was no amputation. Reocclusions occurred in two patients (6.1%). Multivariate logistic regression showed that kinking (odds ratio [OR] 11.9; confidence interval [CI] 3.39-42.1; p=0.0001), first graft generation (OR 2.87; CI 1.25-6.62; p=0.017) and younger age (OR 1.05; CI 1.00-1.09; p=0.034) were independently related to the occurrence of graft limb occlusion.
Acute graft limb occlusion is not rare after EVAR. The frequency of limb occlusion has declined with current stent grafts generation. Although surgery and endovascular treatments are efficient and safe, development of a graft limb kink should lead to aggressive pre-emptive treatment to prevent occlusion.
我们回顾了我们在腔内修复术后肢体闭塞方面的经验,目的是:(1)评估临床模式和治疗选择;(2)评估治疗结果;(3)确定肢体闭塞发生的预测因素。
1995年至2005年间,460例腹主动脉瘤患者接受了多种市售支架型人工血管的选择性治疗。其中有369例使用分叉型支架型人工血管,91例使用主动脉单髂支架型人工血管(共829条肢体)。随访包括体格检查、X线平片、双功超声检查以及在术后1、6、12个月及之后每年进行的螺旋计算机断层扫描。所有相关数据均前瞻性收集并进行回顾性分析。随访时间从术后第0天至104个月,中位随访时间为23.4个月。
33例患者的36条肢体(7.2%)在腔内修复术后第0天至71个月(平均9.5个月)发生闭塞。临床表现为急性缺血11例,静息痛9例,间歇性跛行10例。4例闭塞无症状,2例发生在术中。治疗方法为股-股交叉转流术19例,腋-股旁路移植术3例,血栓切除术联合支架植入术3例,溶栓联合支架植入术9例,保守治疗2例。1例患者(3%)在溶栓后死于多器官功能衰竭。无截肢病例。2例患者(6.1%)发生再闭塞。多因素logistic回归分析显示,人工血管扭曲(比值比[OR]11.9;可信区间[CI]3.39-42.1;p=0.0001)、第一代人工血管(OR 2.87;CI 1.25-6.62;p=0.017)以及较年轻的年龄(OR 1.05;CI 1.00-1.09;p=0.034)与人工血管肢体闭塞的发生独立相关。
腔内修复术后急性人工血管肢体闭塞并不罕见。随着当前支架型人工血管的更新换代,肢体闭塞的发生率有所下降。虽然手术和血管腔内治疗有效且安全,但人工血管肢体发生扭曲时应积极采取预防性治疗以防止闭塞。